Logo of Basma Adeem Medical Co.
Basma Adeem Medical Co. issued today, Dec. 25, the prospectus to float four million shares on the Nomu-Parallel Market.
The offered shares represent 25% of the company's pre-IPO capital of SAR 16 million (divided into 16 million shares) at a nominal value of SAR 1 per share. These shares shall represent 20% of the company’s SAR 20 million post-IPO capital.
The IPO, limited to qualified investors as per the Capital Market Authority’s (CMA) regulations, will run for six working days from Jan. 15-19, 2025.
In Oct. 28, the CMA approved the company's application to float its shares on Nomu.
Basma Adeem Medical was founded in 2012 and is based in Riyadh. It was incepted as a limited liability company before becoming a closed joint-stock Saudi company.
The company’s actual activity is dentistry, offering treatment and cosmetic services. Its commercial registration lists additional activities, including specialty medical complexes, day surgery centers, medical clinics, and managing the operations of these facilities.
Company Profile |
|
Company |
Basma Adeem Medical Co. |
Market |
Nomu-Parallel Market |
Core Activities |
Dental treatment & cosmetics |
Pre-IPO Capital |
SAR 16 mln |
Current Number of Shares |
16 mln |
Post-IPO Capital |
SAR 20 mln |
New Number of Shares |
20 mln |
Par Value |
SAR 1 per share |
IPO Summary |
|
Issue Percentage |
20% of post-increase capital (25% of pre-IPO capital) |
Offered Shares |
4 mln |
IPO Minimum Limit |
100 shares |
IPO Maximum Limit |
999,900 shares |
Offer Period |
Five working days from Jan. 13-19, 2025 |
Final Allocation |
Jan. 22, 2025 |
Surplus Refund (If any) |
Jan. 26, 2025 |
Company Shareholders |
||||
Shareholder |
Pre-IPO |
Post-IPO |
||
Number of Shares (‘000) |
Ownership (%) |
Number of Shares (‘000) |
Ownership (%) |
|
Abdullah Al-Qadeeri |
4030.03 |
25.19% |
4030.03 |
20.15% |
Mohammed Al-Buardi |
3664.73 |
22.90% |
3664.73 |
18.32% |
Talal Al-Nassar |
2748.88 |
17.18% |
2748.88 |
13.74% |
Mohammed Al-Sarhan |
2015.67 |
12.60% |
2015.67 |
10.08% |
Treasury Shares |
1600.00 |
10.00% |
1600.00 |
8.00% |
Sahmeen Investment |
587.09 |
3.67% |
587.09 |
2.94% |
Farraj Al-Balawi |
360.00 |
2.25% |
360.00 |
1.80% |
Nora Al-Sunaidi |
288.00 |
1.80% |
288.00 |
1.44% |
Ibrahim Al-Oqeili |
216.00 |
1.35% |
216.00 |
1.08% |
Abdulaziz Al-Bulaihis |
144.00 |
0.90% |
144.00 |
0.72% |
Yazid Al-Buardi |
86.40 |
0.54% |
86.40 |
0.43% |
Muteb Al-Qadeeri |
86.40 |
0.54% |
86.40 |
0.43% |
Khalid Al-Nassar |
86.40 |
0.54% |
86.40 |
0.43% |
Nora Al-Sahli |
86.40 |
0.54 % |
86.40 |
0.43% |
New Shares for Qualified Investors |
-- |
-- |
4000 |
20.00% |
Total |
20000 |
100% |
21000 |
100% |
Board member Azzam Al-Mufdi holds a 1.83% indirect stake in the company’s pre-IPO share capital, to become 1.47% after the offering. This is given his 5% shareholding in Sahmeen Investment, which owns 3.67% and 2.94% of the company’s pre- and post-IPO shares, respectively.
Additional Information |
|
Financial Advisor & Lead Manager |
Yaqeen Capital |
Receiving Entities |
Alinma Investment - Al Rajhi Capital - SNB Capital - Saudi Fransi Capital - Riyad Capital - ANB Capital - Alistithmar Capital - Albilad Capital - AlJazira Capital - GIB Capital - Alkhabeer Capital - SAB Invest - Sahm Capital - Derayah Financial |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}